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Abstract
The role of minimally invasive surgery in the treatment of transverse colon cancer is still controversial. The aim of this study 
is to investigate the advantages of a totally laparoscopic technique comparing open versus laparoscopic/robotic approach. 
Three hundred and eighty-eight patients with transverse colon cancer, treated with a segmental colon resection, were ret-
rospectively analyzed. Demographic data, tumor stage, operative time, intraoperative complications, number of harvested 
lymph nodes and recovery outcomes were recorded. Recurrences and death were also evaluated during the follow-up. No 
differences were found between conventional and minimally invasive surgery, both for oncological long-term outcomes 
(recurrence rate p = 0.28; mortality p = 0.62) and postoperative complications (overall rate p = 0.43; anemia p = 0.78; nausea 
p = 0.68; infections p = 0.91; bleeding p = 0.62; anastomotic leak p = 0.55; ileus p = 0.75). Nevertheless, recovery outcomes 
showed statistically significant differences in favor of minimally invasive surgery in terms of time to first flatus (p = 0.001), 
tolerance to solid diet (p = 0.017), time to first mobilization (p = 0.001) and hospital stay (p = 0.004). Compared with lapa-
roscopic approach, robotic surgery showed significantly better results for time to first flatus (p = 0.001), to first mobilization 
(p = 0.005) and tolerance to solid diet (p = 0.001). Finally, anastomosis evaluation confirmed the superiority of intracorporeal 
approach which showed significantly better results for time to first flatus (p = 0.001), to first mobilization (p = 0.003) and 
tolerance to solid diet (p = 0.001); moreover, we recorded a statistical difference in favor of intracorporeal approach for infec-
tion rate (p = 0.04), bleeding (p = 0.001) and anastomotic leak (p = 0.03). Minimally invasive approach is safe and effective 
as the conventional open surgery, with comparable oncological results but not negligible advantages in terms of recovery 
outcomes. Moreover, we demonstrated that robotic approach may be considered a valid option and an intracorporeal anas-
tomosis should always be preferred.
Keywords Minimally invasive surgery · Transverse colon cancer · Laparoscopic · Robotic
Introduction
Laparoscopic resection for colorectal cancer has already 
demonstrated long- and short-term benefits both for recov-
ery outcomes and oncological safety [1]. However, the role 
of minimally invasive surgery in the treatment of transverse 
colon cancer is still controversial: the majority of previous 
randomized trials have excluded transverse colon cancer 
because the completeness of resection requires a techni-
cally difficult lymph node dissection around the middle colic 
artery and a hard reconstruction of intestinal continuity [2]. 
Over the last years, the increasing experience in laparoscopic 
and robotic colonic resections among surgeons has led to 
the cumulative publication of several studies comparing the 
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oncological outcomes of the open to the minimally inva-
sive approach for transverse colon cancer, but the real “gold 
standard” is still far to be defined [3, 4].
The aim of the study is to investigate the short- and long-
term outcomes of transverse colon cancer surgery compar-
ing open versus laparoscopic/robotic approach and a sub-
group analysis will be performed to compare laparoscopic 




Three hundred and eighty-eight consecutive patients with 
mid transverse colon cancer, treated with a segmental colon 
resection between 2006 and 2016 in 28 Italian high-volume 
(more than 70 procedures/year) centers were retrospec-
tively analyzed for this study. The protocol for research was 
approved by the institutional review board of all participat-
ing centers.
Mid transverse colon cancer was defined, after surgi-
cal exploration, as a tumor located in the mid part of the 
transverse colon excluding the 10 cm distal third in the left 
colonic angle (splenic flexure) and the 10 cm proximal part 
in the right colonic angle (hepatic flexure) of the transverse 
colon cancer [5].
All patients were operated by expert surgeons (more than 
50 procedures/year) with open or minimally invasive (lapa-
roscopic and robotic) approach.
To minimize the bias related to the different surgical 
techniques, only procedures performed according to the 
standardized criteria were included in the study: transverse 
colectomy is defined as the resection of a variable length 
of bowel included between the hepatic and the splenic flex-
ure, with its lymph vascular supply along the middle colic 
pedicle, whose ligation is done at its origin. Both flexures 
are mobilized and the continuity of the bowel restored by 
fashioning an end-to-end or side-to-side anastomosis. In case 
of minimally invasive approach, the anastomosis was per-
formed with intra- or extracorporeal technique depending on 
the advice of the surgeon. The period between surgery and 
discharge in all enrolled patients followed ERAS periopera-
tive care protocol [6].
Outcomes
Primary outcomes: analyses comparing open versus mini-
mally invasive approach in segmental transverse colectomy 
were performed. Moreover, between patients who underwent 
minimally invasive techniques, we compared outcomes from 
laparoscopic versus robotic approach.
Secondary outcomes: an intra- and extracorporeal anas-
tomosis technique in the minimal invasive surgery was com-
pared in the study population.
Data assessment
Demographic data (gender, age, body mass index (BMI), 
ASA), tumor stage (TNM), operative time, intraoperative 
complications, number of lymph nodes harvested, time to 
first flatus, mobilization, tolerance to solid diet and hospital 
discharge, were recorded.
We also collected data about postoperative surgical com-
plications according to Clavien–Dindo classification [7]: 
surgical wound infections, anastomotic leakage, prolonged 
ileus and abdominal or bowel bleeding. The anastomotic 
leakage was defined as a condition of clinical or radiological 
anastomotic dehiscence that needed or did not need surgical 
revision. All centers performed a complete blood exami-
nation panel daily including C-reactive protein evaluation 
for subclinical leaks until patient discharge. We considered 
as bleeding the cases that required blood transfusion; on 
the other hand, we considered as anemia cases in which 
patients had a decrease in hemoglobin that did not need 
blood transfusions.
Pathological outcomes included the specimen length, 
the distance of the tumor from the proximal and the distal 
margin all measured in centimeters. We also reported the 
number of lymph nodes harvested and how many of these 
contained metastasis. Recurrences and death were also eval-
uated during the follow-up.
Statistical analysis
The analysis was performed with SPSS version 20.0 (IBM, 
Armonk, NY).
Continuous variables are described as median and inter-
quartile range and compared by the Mann–Whitney U test. 
Categorical variables are reported as percentages and com-
pared by the Fisher’s exact test. A p value of less than 0.05 
was defined as statistically significant.
Propensity scores were obtained by a logistic regression 
model. The surgical technique (laparoscopic vs robotic) 
and the anastomosis technique (intra vs extracorporeal) 
were entered into the regression model as the dependent 
variable, and baseline patient and tumor characteristics (age, 
sex, BMI, ASA score and TNM stage) were the independent 
variables. Matching of the propensity scores was obtained 
with the “1:1 nearest neighbor” matching method, with a 
conservative caliper width of 20% of the standard deviation 
of the log of propensity score.
Updates in Surgery 
1 3
Results
A total of 388 patients with mid transverse colon cancer who 
underwent segmental resection were included in the study. 
Of these, 224 (57.7%) patients underwent open surgery and 
164 (42.3%) underwent a minimally invasive approach; 
particularly, 146 (89%) had a laparoscopic segmental colon 
resection and 18 (11%) had a robotic colon resection. In 
terms of post-resection anastomosis, 33 (22.6%) patients 
received an intracorporeal anastomosis and 131 (77.4%) 
patients had an extracorporeal approach.
Primary outcomes
Open vs minimally invasive surgery
Firstly, we compared the characteristics of patients who 
underwent open surgery versus patients who underwent a 
minimally invasive approach. The two treatment groups 
were entirely matched for the analyzed characteristics; thus, 
no propensity matching was needed for further analysis. 
(Table 1).
There were no differences in demographic character-
istics such as sex (53.57% vs 43.9% males; p = 0.2), age 
(72 median, 22.5 IQR vs 72 median, 21.5 IQR; p = 0.1), 
BMI (19 median, 21 IQR vs 19 median, 19 IQR; p = 0.1) 
and ASA score (2 median, 1 IQR vs 2 median, 1 IQR; 
p = 0.5). The two groups were also homogeneous for tumor 
stage characteristics: T (3 median, 0 IQR vs 3 median, 1 
IQR; p = 0.1)—N (0 median, 1 IQR vs 0 median, 1 IQR; 
p = 0.8)—M (0 median, 0 IQR vs 0 median, 0 IQR p = 0.3).
Median operative time was 157 (80 IQR) min for open 
resections and 140 (75 IQR) min for minimally invasive 
approach (p = 0.102).
Recovery outcomes showed statistically significant dif-
ferences in favor of minimally invasive surgery in terms of 
time to first flatus (4 median, 2 IQR vs 3 median, 2 IQR 
days; p = 0.001), tolerance to solid diet (4 median, 3 IQR vs 
4 median, 2 IQR days; p = 0.017), time to first mobilization 
(2 median, 1 IQR vs 1 median, 1 IQR days; p = 0.001) and 
hospital stay (9 median, 5 IQR vs 7.5 median, 4 IQR days; 
p = 0.004).
About complications, we found no statistical differences: 
overall rate (31.7% vs 28%; p = 0.43), anemia (2.2% vs 1.8%; 
p = 0.78), nausea (3.1% vs 2.4%; p = 0.68), infections (4.4% 
vs 4.2%; p = 0.91), bleeding (5.3% vs 4.2%; p = 0.62), anas-
tomotic leak (4.9% vs 3.6%; p = 0.55) and ileus (0.9% vs 
0.6%; p = 0.75) were reported to be comparable between 
groups.
In terms of pathological outcomes, we found no dif-
ferences in specimen length (20 median, 11.6 IQR vs 20 
median, 12 IQR; p = 0.65), proximal margin (7 median, 7 
IQR vs 7 median, 5 IQR; p = 0.46) and distal margin (8 
median, 7 IQR vs 10 median, 6.5 IQR; p = 0.14), number 
of total lymph nodes harvested (13 median, 8 IQR vs 15 
median, 7 IQR; p = 0.33) and number of lymph nodes posi-
tive for metastasis (0 median, 1 IQR vs 0 median, 1 IQR; 
p = 0.19). Finally, the mean follow-up of 3.4 ± 2.1 years for 
open approach and 3.3 ± 2.3 years for minimally invasive 
approach showed no differences between the two groups 
both in terms of recurrence rate (22.8% vs 18.3%; p = 0.28) 
and mortality (6.7% vs 5.5%; p = 0.62).
Laparoscopic vs robotic approach
We compared 146 patients who underwent laparoscopic sur-
gery versus 18 patients underwent robotic surgery: the two 
groups were not homogeneous for baseline characteristics, 
Table 1  Comparison between conventional open approach and mini-
mally invasive surgery







Males (n, %) 120 (53.57%) 72 (43.9%) 0.2
Age (median, IQR) 72 (22.5) 72 (21.5) 0.1
BMI (median, IQR) 19 (21) 19 (19) 0.1
ASA score (median, IQR) 2 (1) 2 (1) 0.5
T (median, IQR) 3 (0) 3 (1) 0.1
N (median, IQR) 0 (1) 0 (1) 0.8
M (median, IQR) 0 (0) 0 (0) 0.3
Complications (n, %) 71 (31.7%) 46 (28%) 0.43
Anemia (n, %) 5 (2.2%) 3 (1.8%) 0.78
Nausea (n, %) 7 (3.1%) 4 (2.4%) 0.68
Infections (n, %) 10 (4.4%) 7 (4.2%) 0.91
Bleeding (n, %) 12 (5.3%) 7 (4.2%) 0.62
Leakage (n, %) 11 (4.9%) 6 (3.6%) 0.55
Ileus (n, %) 2 (0.9%) 1 (0.6%) 0.75
Recurrences (n, %) 51 (22.8%) 30 (18.3%) 0.28
Death (n, %) 15 (6.7%) 9 (5.5%) 0.62
Operative time (median, IQR) 157 (80) 140 (75) 0.102
Clavien (median, IQR) 0 (1) 0 (1) 0.036
Time to first flatus (median, 
IQR)
4 (2) 3 (2) 0.001
Solid diet (median, IQR) 4 (3) 4 (2) 0.017
Mobilization (median, IQR) 2 (1) 1 (1) 0.001
Hospital stay (median, IQR) 9 (5) 7.5 (4) 0.004
Lymph nodes + (median, IQR) 0 (1) 0 (1) 0.19
Total lymph nodes (median, 
IQR)
13 (8) 15 (7) 0.33
Specimen length (median, IQR) 20 (11.6) 20 (12) 0.65
Proximal margin (median, IQR) 7 (7) 7 (5) 0.46
Distal margin (median, IQR) 8 (7) 10 (6.5) 0.14
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so propensity score match was applied, resulting in a study 
population of 36 patients: 18 for each group (Table 2a, b).
Post-matching no differences were found in sex (88.8% 
vs 83.3,5% males; p = 0.99), age (73.2 median, 5.7 IQR vs 
74.2 median, 6.7 IQR; p = 0.82), BMI (26.6 median, 5.6 IQR 
vs 25 median, 10.5 IQR kg/m2; p = 0.7) and ASA score (2 
median, 0 IQR vs 3 median, 1 IQR; p = 0.43). About tumor 
staging, we recorded no differences between groups [T: 2 
Table 2  (a) Pre- and post-matching data between laparoscopic and robotic group (b) comparison between laparoscopic and robotic approach
IQR interquartile range, BMI body mass index, ASA American Society of Anesthesiologists
a
Pre-matching Laparoscopic (n = 146) Robotic
(n = 18)
p
Males (n, %) 57 (39%) 15 (83.3%) 0.001
Age (median, IQR) 73.5 (4) 74.2 (6.7) 0.04
BMI (median, IQR) 25 (6) 25 (10.5) 0.001
ASA score (median, IQR) 2 (1) 3 (1) 0.001
T (median, IQR) 3 (1) 3 (0) 0.001
N (median, IQR) 0 (1) 0.5 (1) 0.03
M (median, IQR) 0 (0) 0 (0) 0.001
Post-matching Laparoscopic (n = 18) Robotic
(n = 18)
p
Males (n, %) 16 (88.8%) 15 (83.3%) 0.99
Age (median, IQR) 73.2 (5.7) 74.2 (6.7) 0.82
BMI (median, IQR) 26.6 (5.6) 25 (10.5) 0.7
ASA score (median, IQR) 2 (0) 3 (1) 0.43
T (median, IQR) 2 (2) 3 (0) 0.78
N (median, IQR) 0 (0) 0.5 (1) 0.48
M (median, IQR) 0 (0) 0 (0) 0.59
b
Laparoscopic (n = 18) Robotic
(n = 18)
p
Complications (n, %) 7 (28.8%) 4 (22.2%) 0.47
Anemia (n, %) 2 (11.1%) 1 (5.5%) 0.91
Nausea (n, %) 3 (16.6%) 1 (5.6%) 0.6
Infections (n, %) 5 (27.7%) 2 (11.1%) 0.4
Bleeding (n, %) 5 (27.7%) 2 (11.1%) 0.4
Leakage (n, %) 4 (22.2%) 2 (11.1%) 0.65
Ileus (n, %) 1 (5.5%) 0 0.98
Recurrences (n, %) 6 (33.3%) 4 (22.2%) 0.71
Death (n, %) 7 (38.8%) 2 (11.1%) 0.12
Operative time (median, IQR) 148.5 (51.2) 157.5 (60) 0.82
Clavien (median, IQR) 0 (0.7) 0 (0) 0.266
Time to first flatus (median, IQR) 3.5 (1.7) 2 (0.7) 0.001
Solid diet (median, IQR) 4.5 (1.7) 2 (0) 0.001
Mobilization (median, IQR) 1.5 (1) 1 (0) 0.005
Hospital stay (median, IQR) 8 (4) 8 (2) 0.33
Lymph nodes + (median, IQR) 0 (0.7) 0 (1) 0.276
Total lymph nodes (median, IQR) 11.5 (9.5) 14.5 (3.7) 0.774
Specimen length (median, IQR) 20 (6.2) 30 (3) 0.47
Proximal margin (median, IQR) 7.5 (2) 8 (9) 0.199
Distal margin (median, IQR) 9.7 (5.2) 18 (8) 0.42
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(2 IQR) vs 3 (0 IQR) p = 0.78; N: 0 (0 IQR) vs 0.5 (1 IQR) 
p = 0.48; M: 0 (0 IQR) vs 0 (0 IQR) p = 0.59].
Also, operative time was comparable between the two 
approaches [148.5 (51.2 IQR) vs 157.5 (60 IQR) min 
p = 0.82].
In terms of recovery, robotic approach showed signifi-
cantly better results for time to first flatus (3.5 median, 1.7 
IQR vs 2 median, 0.7 IQR days; p = 0.001), to first mobiliza-
tion (1.5 median, 1 IQR vs 1 median, 0 IQR days; p = 0.005) 
and tolerance to solid diet (4.5 median, 1.7 IQR vs 2 median, 
0 IQR days; p = 0.001); no differences were recorded in 
hospital stay (8 median, 4 IQR vs 8 median, 2 IQR days; 
p = 0.33).
About complications, we recorded no statistical differ-
ences between the two approaches for all examined out-
comes: overall rate (28.8% vs 22.2%; p = 0.47), anemia 
(11.1% vs 5.5%; p = 0.91), nausea (16.6% vs 5.6%; p = 0.6), 
infections (27.7% vs 11.1%; p = 0.4), bleeding (27.7% vs 
11.1%; p = 0.4), anastomotic leak (22.2% vs 11.1%; p = 0.65) 
and ileus (5.5% vs 0%; p = 0.98).
Analysis of pathological outcomes showed no differences 
in the number of lymph nodes harvested (11.5 median, 9.5 
IQR vs 14.5 median, 3.7 IQR; p = 0.77), lymph nodes posi-
tive for metastasis (0 median, 0.7 IQR vs 0 median, 1 IQR; 
p = 0.37), proximal margin (7.5 median, 2 IQR vs 8 median, 
9 IQR; p = 0.19), distal margin (9.7 median, 5.2 IQR vs 18 
median, 8 IQR; p = 0.42) and specimen length (20 median, 
6.2 IQR vs 30 median, 3 IQR; p = 0.47).
At the mean follow-up of 3.6 ± 2.4 years for laparoscopic 
and 3.4 ± 2.2 years for robotic approach, data showed no 
differences between the two groups both in terms of recur-
rence rate (33.3% vs 22.2%; p = 0.71) and mortality (38.8% 
vs 11.1%; p = 0.12).
Secondary outcome
Intra‑ versus extracorporeal anastomosis
Overall, 33 patients who underwent intracorporeal anas-
tomosis were compared with 131 patients who underwent 
extracorporeal anastomosis: the two groups showed signifi-
cant differences in demographic characteristics, so these 
inhomogeneities required propensity score match analysis 
(Table 3a, b).
Post-matching, the study population was composed of 66 
patients (33 for each group) and there were no significant 
differences between the groups with regard to the base-
line demographic variables [sex: 54.5% vs 45.45% males, 
p = 0.54; age: 74 (12 IQR) vs 69 (13 IQR) years, p = 0.21; 
BMI: 25.6 (6.4 IQR) vs 22.7 (5.7 IQR) kg/m2, p = 0.47; 
ASA: 2.5 (1.1 IQR) vs 3 (1 IQR), p = 0.33] as well as the 
stage of the tumors [T: 3 (1 IQR) vs 3 (1 IQR), p = 0.77; N: 
0 (1 IQR) vs 0 (1 IQR), p = 0.12; M: 0 (0 IQR) vs 0 (0 IQR), 
p = 0.56).
Operative time was significantly shorter for intracorporeal 
anastomosis (160 median, 105 IQR vs 185 median, 70 IQR 
mins; p = 0.005).
Recovery outcomes showed that intracorporeal anasto-
mosis had significantly better results for time to first flatus 
(3 median, 1 IQR vs 4 median, 1 IQR days; p = 0.001), to 
first mobilization (1 median, 1 IQR vs 2 median, 1 IQR days; 
p = 0.003) and tolerance to solid diet (4 median, 1 IQR vs 
5 median, 1 IQR; p = 0.001); no differences were recorded 
in hospital stay (7 median, 3 IQR vs 8 median, 4 IQR days; 
p = 0.56).
In terms of complications, we recorded a statistical dif-
ference in favor of intracorporeal approach for overall rate 
(12.1% vs 48.5%; p = 0.001), infections (6.1% vs 24.2%; 
p = 0.04), bleeding (6.1% vs 39.4%; p = 0.001) and anasto-
motic leak (3% vs 18.1%; p = 0.03).
Analysis of pathological outcomes showed no differences 
in the number of lymph nodes harvested (11 median, 8 IQR 
vs 11 median, 9 IQR; p = 0.61), lymph nodes positive for 
metastasis (0 median, 2 IQR vs 0 median, 0 IQR; p = 0.18), 
proximal margin (8 median, 4 IQR vs 7 median, 4 IQR; 
p = 0.43), distal margin (10 median, 8 IQR vs 8 median, 5 
IQR; p = 0.62) and specimen length (21 median, 9 IQR vs 
19 median, 7 IQR; p = 0.13).
Data from a mean follow-up of 3.1 ± 2.2 years for intra-
corporeal and 3.2 ± 2.3 years for extracorporeal anastomo-
sis again showed the same results for the two groups, both 
in terms of recurrence rate (18.2% vs 18.2%; p = 0.99) and 
mortality (0% vs 6.1%; p = 0.15).
Discussion
Recent RCTs and several reviews have demonstrated that 
minimally invasive surgery is nowadays considered the 
gold standard approach for colorectal cancers with excel-
lent short-term outcomes and equivalent long-term onco-
logic outcomes compared to conventional open surgery 
[8–10]. However, less is known about minimally invasive 
approach to transverse colon cancer, both for its relatively 
low incidence and for its technical difficulties, which are 
higher than that for other site colon cancers: the challenging 
localization of the neoplasm, isolation and ligation of the 
middle colic vessels, lymphadenectomy, anatomical features 
of the transverse colon and its relationships with the spleen, 
pancreas, superior mesenteric vein, duodenum and Treitz 
ligament make transverse colon mobilization and dissection 
a challenging procedure.
Cumulating surgeons experience in this kind of surgical 
approach resulted in several studies which have compared 
minimally invasive and open surgery for transverse colon 
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cancer [11–13]; however, the interpretation of the data is 
still limited. The major limitation is the complete absence 
in literature of studies which analyze and compare the open 
versus laparoscopic approach to transverse colon cancer 
on a specific type of resection: in fact, we can only find 
Table 3  (a) Pre- and post-matching data between intracorporeal and extracorporeal anastomosis (b) comparison between intracorporeal and 
extracorporeal anastomosis







Males (n, %) 18 (54.54%) 54 (41.22%) 0.16
Age (median, IQR) 74 (12) 67 (10.6) 0.01
BMI (median, IQR) 25.6 (6.4) 21.5 (10.7) 0.001
ASA score (median, IQR) 2.5 (1.1) 2.1 (0.6) 0.001
T (median, IQR) 3 (1) 3 (1) 0.04
N (median, IQR) 0 (1) 0 (0) 0.01
M (median, IQR) 0 (0) 0 (0) 0.001
Post-matching Intracorporeal (n = 33) Extracorporeal
(n = 33)
p
Males (n, %) 18 (54.54%) 15 (45.45%) 0.54
Age (median, IQR) 74 (12) 69 (13) 0.21
BMI (median, IQR) 25.6 (6.4) 22.7 (5.7) 0.47
ASA score (median, IQR) 2.5 (1.1) 3 (1) 0.33
T (median, IQR) 3 (1) 3 (1) 0.77
N (median, IQR) 0 (1) 0 (1) 0.12
M (median, IQR) 0 (0) 0 (0) 0.56
b
Intracorporeal (n = 33) Extracorporeal
(n = 33)
p
Complications (n, %) 4 (12.1%) 15 (48.5%) 0.001
Anemia (n, %) 1 (3%) 2 (1.5%) 0.55
Nausea (n, %) 1 (3%) 2 (1.5%) 0.55
Infections (n, %) 1 (3%) 6 (18.1%) 0.04
Bleeding (n, %) 1 (3%) 6 (18.1%) 0.04
Leakage (n, %) 0 6 (18.1%) 0.03
Ileus (n, %) 0 1 (3%) 0.314
Recurrences (n, %) 6 (18.2%) 6 (18.2%) 0.99
Death (n, %) 0 2 (6.1%) 0.151
Operative time (median, IQR) 160 (105) 185 (70) 0.005
Clavien (median, IQR) 0 (0) 0 (1) 0.266
Time to first flatus (median, IQR) 3 (1) 4 (1) 0.001
Solid diet (median, IQR) 4 (1) 5 (1) 0.001
Mobilization (median, IQR) 1 (1) 2 (1) 0.003
Hospital stay (median, IQR) 7 (3) 8 (4) 0.564
Lymph nodes + (median, IQR) 0 (2) 0 (0) 0.184
Total lymph nodes (median, IQR) 11 (8) 11 (9) 0.612
Specimen length (median, IQR) 21 (9) 19 (7) 0.136
Proximal margin (median, IQR) 8 (4) 7 (4) 0.432
Distal margin (median, IQR) 10 (8) 8 (5) 0.623
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conclusions based on the mixed results from extended and 
segmental resections.
We have for the first time, in our best knowledge, com-
pared open versus laparoscopic surgery for segmental resec-
tion of transverse colon cancer.
Since knowledge is lacking about the real surgical “gold 
standard” for the treatment of transverse colon cancer, the 
decision whether to perform an extended colectomy or a 
segmental transverse colectomy is based on a surgeon’s pref-
erence and segmental resection is one of the possibilities to 
treat this tumor location [14–16].
A recent systematic review with meta-analysis by Milone 
et al. [17] which involved 11,687 patients found that there 
were no statistical differences between transverse colectomy 
and extended hemicolectomy in short- and long-term onco-
logical outcomes, concluding that the current literature gives 
the opportunity to perform either a segmental resection or an 
extended hemicolectomy to treat transverse colon cancer. In 
our study, we evaluated the advantages of a totally minimally 
invasive approach to transverse colon cancer and comparing 
it to the outcomes of open surgery. Evaluating the differ-
ences between conventional and minimally invasive surgery, 
our findings demonstrated that both approaches have similar 
oncological long-term outcomes without discrepancies in 
terms of postoperative complications. Nevertheless, in line 
with current literature [4, 18], minimally invasive techniques 
revealed better recovery results: return of bowel function and 
resumption of solid diet occurred significantly earlier in the 
minimally invasive group with a significantly shorter length 
of hospital stay. Thus, on the basis of our results, we can 
confirm that the minimally invasive approach to transverse 
colon cancer is feasible and safe, with similar operative time, 
morbidity and mortality rates when compared to the open 
approach.
In the area of mini-invasive surgery, we refined our anal-
ysis comparing patients who had undergone laparoscopic 
resection with those undergoing robotic resection. The cur-
rent literature is very poor about the possibility of perform-
ing a transverse colon resection with a robotic approach 
but, because of high technical demand of this procedure, 
the advantages of robotic surgery, such as stable three-
dimensional magnified view, can be maximized. de Angelis 
et al. [19] described their first experience on 22 patients who 
underwent robotic transverse colectomy matched with 22 
patients who received a laparoscopic resection. The authors 
found no group differences in complications, recovery and 
oncological outcomes except for conversion rate which was 
higher in the laparoscopic population. Similarly, Jung and 
colleagues [20] described three robotic transverse colecto-
mies, using a hand-sewn intracorporeal anastomosis; the 
authors found encouraging oncological outcomes with a low 
rate of complications and concluded that robotic transverse 
colectomy seems to be a safe and feasible technique which 
may minimize the necessity of mobilizing both colonic flex-
ures, with facilitated intracorporeal anastomosis.
In our results, the analysis between patients who under-
went laparoscopic or robotic surgery demonstrated equiva-
lence of the two approaches except for the time to first flatus, 
tolerance to solid diet and patients’ mobilization which were 
lower in case of robotic procedures.
Finally, anastomosis evaluation confirmed that intracor-
poreal approach shows some advantages in terms of compli-
cations and recovery outcomes. As previously demonstrated 
[21], this can be easily explained because an intracorporeal 
end-to-end anastomosis allows to avoid an excessive dissec-
tion and colonic flexure takedown to extract the specimen; 
on the other hand, an extracorporeal anastomosis requires 
a mobilization of transverse colonic mesentery and of both 
colonic flexure to reach the mini-laparotomy site [22, 23]. 
van Oostendorp and colleagues [24] recently furnished a 
systematic review on 1492 patients who underwent lapa-
roscopic right colectomy: they found a larger decrease in 
short-term morbidity and a significant decrease in the length 
of stay in favor of intracorporeal anastomosis. Similarly, 
Kelly et al.[25] analyzed data from 21 consecutive patients 
with a right colon cancer who underwent robotic resection 
with an intracorporeal anastomosis. The authors observed 
a low complication rate with good oncological and recov-
ery outcomes, concluding that an intracorporeal approach 
is safe and feasible. Despite these studies, current literature 
lacks data about differences and advantages of intra- and 
extracorporeal anastomosis in transverse colon resections; 
our results, by this point of view, provide support to the 
effectiveness of intracorporeal anastomotic technique to pro-
vide surgeons a clearer perspective on which to perform a 
conscious choice during this type of colic resection.
Conclusion
Our results confirm that minimally invasive approach, both 
laparoscopic and robotic, is as safe and effective in trans-
verse colon surgery as the conventional open surgery, with 
comparable oncological results and not negligible advan-
tages in terms of recovery outcomes. Moreover, our analy-
sis demonstrated that fashioning intracorporeal anastomosis 
determines an advantage in terms of recovery outcomes and 
complications rate.
Limitations
The major limitation of our study is its retrospective design 
and the small sample size which do not allow us to draw 
final conclusions; moreover, the multicentric enrollment 
which lasted 10 years does not permit to exclude a patients’ 
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selection bias, particularly since different devices were used. 
Finally, because of a lack of consensus on the definition 
and assessment of post-surgical infections, results about this 
aspect must be read with caution.
Therefore, well-designed prospective multicentric trials 
and RCTs with homogeneous parameters are needed to set 
a real “gold standard” surgical procedure.
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